Compass Therapeutics Income Statement (2023-2025) | CMPX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating items
Research & Development 6.64M10.22M8.83M12.43M9.52M11.17M8.61M13.04M13.05M16.41M12.83M
Selling, General & Administrative 3.07M3.11M3.10M2.97M3.25M4.72M3.63M3.54M4.91M4.65M2.99M
Operating Expenses 9.71M13.34M11.93M15.39M12.77M15.89M12.24M16.57M17.97M21.07M15.82M
Operating Income -9.71M-13.34M-11.93M-15.39M-12.77M-15.04M-12.24M-16.57M-17.97M-21.07M-15.82M
EBIT -9.71M-13.34M-11.93M-15.39M-12.77M-15.04M-12.24M-16.57M-17.97M-21.07M-15.82M
Non-operating items
Interest & Investment Income 1.87M1.96M1.98M
Other Non Operating Income 1.87M2.06M1.96M1.98M1.98M1.97M1.76M1.54M1.33M1.19M1.56M
Non Operating Income 1.87M2.06M1.96M1.98M1.98M1.97M1.76M1.54M1.33M1.19M1.56M
Net income details
EBT -7.84M-11.28M-9.96M-13.41M-10.79M-13.08M-12.24M-16.57M-16.63M-21.07M-15.82M
Profit After Tax -7.84M-11.28M-9.96M-13.41M-10.79M-13.08M-10.48M-15.03M-16.63M-19.88M-14.26M
Income from Continuing Operations -7.84M-11.28M-9.96M-13.41M-10.79M-13.08M-12.24M-16.57M-16.63M-21.07M-15.82M
Consolidated Net Income -7.84M-11.28M-9.96M-13.41M-10.79M-13.08M-12.24M-16.57M-16.63M-21.07M-15.82M
Income towards Parent Company -7.84M-11.28M-9.96M-13.41M-10.79M-13.08M-12.24M-16.57M-16.63M-21.07M-15.82M
Net Income towards Common Stockholders -7.84M-11.28M-9.96M-13.41M-10.79M-13.08M-12.24M-16.57M-16.63M-21.07M-15.82M
Additional items
EPS (Basic) -0.06-0.09-0.08-0.10-0.08-0.10-0.08-0.11-0.12-0.14-0.08
Shares Outstanding (Weighted Average) 126.51M126.51M127.46M127.49M137.59M137.59M137.59M137.59M138.28M138.28M138.28M
EBITDA -7.68M-11.64M-9.89M-12.95M-10.91M-13.08M-9.90M-15.31M-16.65M-19.86M-14.19M